ClinicalTrials.gov
public full text
Public Domain
Efficacy of Upadacitinib After NECS in Vitiligo
The goal of this clinical trial is to investigate the efficacy of upadacitinib after NECS in participants with vitiligo. The main question it aims to answer is: whether the short time use of upadacitinib after NECS will improve NECS efficacy. Participants in the experimental group will receive upadacitinib after NECS, while Participants in the control group will receive NECS only.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Restarting Triple Therapy With Robust Monitoring for Adverse Events (RETRIAL)#855740
- Resolution of Thrombi in Left Atrial Appendage With Edoxaban#982745
- Diseño e implementación de un modelo interpretable para la predicción de mortalidad en pacientes con sepsis utilizando la base de datos MIMIC-IV#477344
- Long-Term Follow Up Study#800781
- Safety and Efficacy of SIMBRINZA® BID as an Adjunctive to DUOTRAV®#67713
Record · ID 895544
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive